EN-US Wed, 19 Jun 2013 05:04:59 -0400 245575 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k5TkMi8RLuM/company-news-for-may-13-2013-corporate-summary-cm245575 Investing Business Investing Ideas Stocks •    DiamondRock Hospitality Company (NYSE: DRH ) posted first quarter earnings per share of $0.14, ahead of the Zacks Consensus Estimate of $0.09 •  <img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/k5TkMi8RLuM" height="1" width="1"/> Mon, 13 May 2013 18:18:13 Z 2013-05-13T15:22:47Z Zacks Equity Research AWR BSTC DRH ERF USA http://www.nasdaq.com/article/company-news-for-may-13-2013-corporate-summary-cm245575 232528 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ks-zTKSUuK8/positive-data-on-bstcs-xiaflex-analyst-blog-cm232528 Investing Business Stocks BioSpecifics Technologies ( BSTC ) recently announced positive top line data from a phase IIa study on Xiaflex for the potential treatment of frozen shoulder syndrome (FSS) in adults.<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Ks-zTKSUuK8" height="1" width="1"/> Tue, 02 Apr 2013 03:05:01 Z 2013-04-02T00:11:41Z Zacks Equity Research AUXL BSTC FSS LCI WX http://www.nasdaq.com/article/positive-data-on-bstcs-xiaflex-analyst-blog-cm232528 202695 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FlpJjT6FXAI/standard-review-for-auxiliums-drug-analyst-blog-cm202695 Investing Business Stocks Auxilium Pharmaceuticals, Inc. ( AUXL ) recently announced that the FDA has accepted its supplemental Biologics License Application (sBLA) for Xiaflex (clostridial collagenase for<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/FlpJjT6FXAI" height="1" width="1"/> Fri, 28 Dec 2012 20:00:01 Z 2012-12-28T16:45:29Z Zacks Equity Research ALPMY AUXL BSTC VRX http://www.nasdaq.com/article/standard-review-for-auxiliums-drug-analyst-blog-cm202695 188452 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lRoFDbZef-I/weak-quarter-from-auxilium-pharma-analyst-blog-cm188452 Investing Business Stocks Auxilium Pharmaceuticals, Inc. ( AUXL ) reported a loss of 21 cents per share in the third quarter of 2012, wider than the year-ago loss of 8 cents and the Zacks Consensus Estimate of a<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/lRoFDbZef-I" height="1" width="1"/> Fri, 09 Nov 2012 01:01:01 Z 2012-11-08T21:39:23Z Zacks Equity Research ALIOF AUXL BSTC GSK TRT http://www.nasdaq.com/article/weak-quarter-from-auxilium-pharma-analyst-blog-cm188452 160768 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pr9EEZYZdGk/a-profitable-quarter-for-auxilium-analyst-blog-cm160768 Investing Business Stocks Auxilium Pharmaceuticals, Inc. ( AUXL ) swung to a profit in the second quarter of 2012 with earnings coming in at 16 cents per share, well above the year-ago loss of 11 cents and the Zacks<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Pr9EEZYZdGk" height="1" width="1"/> Thu, 02 Aug 2012 17:21:26 Z 2012-08-02T14:24:30Z Zacks Equity Research ALIOF AUXL BSTC GSK http://www.nasdaq.com/article/a-profitable-quarter-for-auxilium-analyst-blog-cm160768 140938 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YAXxkIEs47I/loss-narrows-at-auxilium-analyst-blog-cm140938 Investing Business Stocks Auxilium Pharmaceuticals, Inc. ( AUXL ) reported a first quarter loss of 4 cents per share, well below the year-ago loss of 25 cents and the Zacks Consensus Estimate of a loss of 12<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/YAXxkIEs47I" height="1" width="1"/> Mon, 14 May 2012 18:07:09 Z 2012-05-14T15:11:03Z Zacks Equity Research AUXL BSTC http://www.nasdaq.com/article/loss-narrows-at-auxilium-analyst-blog-cm140938 101412 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0nGDuz1GL1Y/merck-reports-strong-q3-results-on-gardasil-and-diabetes-med-cm101412 Investing Investing Ideas Stocks Technology (Written by Alexander Crawford. Institutional data sourced from Fidelity.) At a time of significant restructuring to adapt to generic competition, Merck & Co. ( MRK ) reported an otherwise<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/0nGDuz1GL1Y" height="1" width="1"/> Mon, 07 Nov 2011 06:19:49 Z 2011-11-07T01:19:51Z Kapitall ACHN AFFY BONE BSTC INSM ONTY PIP SNSS SSRX http://www.nasdaq.com/article/merck-reports-strong-q3-results-on-gardasil-and-diabetes-med-cm101412 90828 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n81gMAWEAAs/biotech-bargains-biotech-analysts-see-buying-opportunities-from-selloff-cm90828 Investing Investing Ideas Stocks (Written by Alexander Crawford. Current assets and liabilities CAGR, cash and debt data sourced from Screener.co, all other data sourced from Finviz.) The biotech industry often gets<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/n81gMAWEAAs" height="1" width="1"/> Wed, 17 Aug 2011 02:34:58 Z 2011-08-16T22:35:00Z Kapitall BSTC ENZN PTX SCMP SUPG THRX http://www.nasdaq.com/article/biotech-bargains-biotech-analysts-see-buying-opportunities-from-selloff-cm90828